Validation group | Scenario | ρ | LB (GSD) | b1 | R2adj | RMSE (GSD) | |
---|---|---|---|---|---|---|---|
Direct EBV | Domestic (≥ 15 off) (n = 1382) | NATAPR | 0.95 | − 0.14 | 0.96 | 0.90 | 0.18 |
BLENDAPR | 0.99 | 0.01 | 0.96 | 0.97 | 0.10 | ||
Domestic (< 15 off) (n = 94) | NATAPR | 0.63 | − 0.52 | 0.66 | 0.39 | 0.49 | |
BLENDAPR | 0.97 | − 0.10 | 0.96 | 0.94 | 0.15 | ||
Foreign (n = 3470) | NATAPR | 0.24 | − 0.22 | 0.69 | 0.06 | 0.62 | |
BLENDAPR | 0.97 | − 0.17 | 1.13 | 0.94 | 0.15 | ||
Maternal EBV | Domestic (≥ 15 off) (n = 491) | NATAPR | 0.99 | 0.05 | 1.01 | 0.98 | 0.07 |
BLENDAPR | 0.98 | − 0.04 | 0.96 | 0.95 | 0.11 | ||
Domestic (< 15 off) (n = 51) | NATAPR | 0.86 | 0.13 | 0.80 | 0.73 | 0.22 | |
BLENDAPR | 0.84 | − 0.05 | 0.72 | 0.71 | 0.23 | ||
Foreign (n = 1165) | NATAPR | 0.51 | 0.06 | 0.98 | 0.26 | 0.27 | |
BLENDAPR | 0.83 | 0.06 | 0.57 | 0.69 | 0.17 |